3D Cell Culture Market: by Technology (Scaffold-free platforms, Bioreactors, Microchips, Gels, Others), by Application (Stem cell biology, Drug discovery, Research, Tissue engineering, Others), by End User (Hospitals, Diagnostic centers, Biotechnology and pharmaceutical industries, Others), and Geography.

   

Purchase Option

$ 3000
$ 4400
$ 6600
$ 8900

The global 3d cell culture market is expected to grow at a CAGR of 16% during the forecast period 2022 to 2028. Cell culture is the procedure in which cells are grown usually outside their natural environment, under controlled conditions. These cells are isolated from the living tissue cells and are maintained under controlled conditions. The conditions at which cells are grown vary for each type of cell. Earlier, the 2D cell culture was used in the laboratories which were unable to reproduce at the created environment. This lead to the advent of 3D cell culture technology, which replicate at the vivo environment. The 3D technology helps the cell to interact with the 3D dimensional surroundings. The 3D Cell Culture Market technology offers a wide range of applications in the domains of drug screening, regenerative medicine, stem cell therapies, cancer research, and cell biology since 3D cell cultures may imitate the structure, activity, and milieu of in-vivo tissues. In 3D cell cultures, the extracellular matrix facilitates cell–cell communication through direct contact, similar to the in-vivo environment, by secreting cytokines and trophic substances. These parameters can be altered in a 2D environment, which can have a major impact on cell–cell communication and, as a result, cell morphology and proliferation. Because 2D cultures can't replicate the architecture and intricate cellular matrices that 3D cultures can, this technique is gaining traction in the healthcare research field. Furthermore, 3D cell cultures can produce more efficient outcomes and lower the overall cost of the R&D process.

Key Development: In Feb 2022, Corning Incorporated launched Corning Matribot bioprinter, a breakthrough technology that eliminates the need for cold blocks, ice buckets, or a cold room when dispensing and printing Corning Matrigel matrix, collagen, and other temperature-sensitive hydrogels. The device can also be used to bioprint with alginate-based bioinks and other hydrogels that require ambient temperature. In Jan 2022, Amerigo introduced Polycaprolactone for research uses. This novel substance will aid scientists in bioprinting rigid tissues like bones and cartilage. It's a polymer that allows for better control of the final 3D structure's mechanical properties.

3d Cell Culture Market Summary

Study Period

2023-29

Base Year

2022

CAGR

16%

Largest Market

North America

Fastest Growing Market

Asia Pacific
Dynamics

The technological advancements is the major factor influencing the growth of the 3D cell culture market. The increasing research activities are also adding aid to the growth of the 3D cell culture market. The increasing number of the organ transplantation incidences and the growing number of the patient population with requirement of the organ transplantation is the one of the key factor driving the growth of the 3D cell Culture market. The increasing investment by biotechnology and the pharmaceutical companies for 3D cell culture is also flourishing the market. The ban on research over the animals is also a factor responsible for the growth of the market. However, the higher investments in the initial stages and dearth of skilled professionals are likely to hamper the growth of the market.

Key Features of the Reports

  • The report provides granular level information about the market size, regional market share, historic market (2018 to 2022) and forecast (2023 to 2029)
  • The report covers in-detail insights about the competitor’s overview, company share analysis, key market developments, and their key strategies
  • The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
  • The report tracks recent innovations, key developments and startup’s details that are actively working in the market
  • The report provides plethora of information about market entry strategies, regulatory framework and reimbursement scenario
  • The report analyses the impact of socio-political environment through PESTLE Analysis and competition through Porter’s Five Force Analysis in addition to recent technology advancements and innovations in the market

3d Cell Culture Market Segmentation

Technology
  • Scaffold-free Platforms
  • Bioreactors
  • Microchips
  • Gels
  • Others
Application
  • Stem Cell Biology
  • Drug Discovery
  • Research
  • Tissue Engineering
  • Others
End User
  • Biotechnology and Pharmaceutical Industries
  • Hospitals
  • Others
LOCATION

Geography

Frequently Asked Questions

The CAGR of the 3d cell culture market is 16% over the forecast period (2022 - 2028)

3D Biomatrix, Reinnervate Ltd, Becton Dickinson and Company, 3D Biotek LLC, Thermo Fisher Scientific

Asia Pacific is the fastest-growing region for 3d cell culture market  

1. Executive Summary 2. Global 3D Cell Culture Market Introduction 2.1. Global 3D Cell Culture Market – Taxonomy 2.2. Global 3D Cell Culture Market –Definitions 2.2.1. Technology 2.2.2. Application 2.2.3. End User 3. Global 3D Cell Culture Market Dynamics 3.1. Drivers 3.2. Restraints 3.3. Opportunities/Unmet Needs of the Market 3.4. Trends 3.5. Global3D Cell Culture Market Dynamic Factors - Impact Analysis 3.6. Global 3D Cell Culture Market – Competition Landscape 3.7. Epidemiology 4. Global 3D Cell Culture Market Analysis,2013 - 2017 and Forecast, 2018 – 2024 4.1. Market Analysis, 2013 - 2017 and Forecast, 2018 - 2024 (Revenue, USD Mn) 4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) 4.3. Market opportunity analysis 5. Global 3D Cell Culture Market, By Technology, 2013 - 2017 and Forecast, 2018 - 2024 (Revenue, USD Mn) 5.1. Scaffold-free Platforms 5.1.1. Market Analysis, 2013 - 2017 and Forecast, 2018 - 2024 (Revenue, USD Mn) 5.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 5.1.3. Market Opportunity Analysis 5.2. Bioreactors 5.2.1. Market Analysis, 2013 - 2017 and Forecast, 2018 - 2024 (Revenue, USD Mn) 5.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 5.2.3. Market Opportunity Analysis 5.3. Microchips 5.3.1. Market Analysis, 2013 - 2017 and Forecast, 2018 - 2024 (Revenue, USD Mn) 5.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 5.3.3. Market Opportunity Analysis 5.4. Gels 5.4.1. Market Analysis, 2013 - 2017 and Forecast, 2018 - 2024 (Revenue, USD Mn) 5.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 5.4.3. Market Opportunity Analysis 5.5. Others 5.5.1. Market Analysis, 2013 - 2017 and Forecast, 2018 - 2024 (Revenue, USD Mn) 5.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 5.5.3. Market Opportunity Analysis 6. Global 3D Cell Culture Market Forecast, By Application,2013 - 2017 and Forecast, 2017 – 2024 6.1. Stem Cell Biology 6.1.1. Market Analysis, 2013 - 2017 and Forecast, 2018 - 2024 (Revenue, USD Mn) 6.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 6.1.3. Market Opportunity Analysis 6.2. Drug Discovery 6.2.1. Market Analysis, 2013 - 2017 and Forecast, 2018 - 2024 (Revenue, USD Mn) 6.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 6.2.3. Market Opportunity Analysis 6.3. Research 6.3.1. Market Analysis, 2013 - 2017 and Forecast, 2018 - 2024 (Revenue, USD Mn) 6.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 6.3.3. Market Opportunity Analysis 6.4. Tissue Engineering 6.4.1. Market Analysis, 2013 - 2017 and Forecast, 2018 - 2024 (Revenue, USD Mn) 6.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 6.4.3. Market Opportunity Analysis 6.5. Others 6.5.1. Market Analysis, 2013 - 2017 and Forecast, 2018 - 2024 (Revenue, USD Mn) 6.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 6.5.3. Market Opportunity Analysis 7. Global 3D Cell Culture Market Forecast, By End User, 2013 - 2017 and Forecast, 2018 - 2024 (Revenue, USD Mn) 7.1. Biotechnology and Pharmaceutical Industries 7.1.1. Market Analysis, 2013 - 2017 and Forecast, 2018 - 2024 (Revenue, USD Mn) 7.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 7.1.3. Market Opportunity Analysis 7.2. Hospitals 7.2.1. Market Analysis, 2013 - 2017 and Forecast, 2018 - 2024 (Revenue, USD Mn) 7.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 7.2.3. Market Opportunity Analysis 7.3. Others 7.3.1. Market Analysis, 2013 - 2017 and Forecast, 2018 - 2024 (Revenue, USD Mn) 7.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 7.3.3. Market Opportunity Analysis 8. Global 3D Cell Culture Market Forecast, By Region, 2013 - 2017 and Forecast, 2018 - 2024 (Revenue, USD Mn) 8.1. North America 8.1.1. Market Analysis, 2013 - 2017 and Forecast, 2018 - 2024 (Revenue, USD Mn) 8.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 8.1.3. Market Opportunity Analysis 8.2. Europe 8.2.1. Market Analysis, 2013 - 2017 and Forecast, 2018 - 2024 (Revenue, USD Mn) 8.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 8.2.3. Market Opportunity Analysis 8.3. Asia-Pacific 8.3.1. Market Analysis, 2013 - 2017 and Forecast, 2018 - 2024 (Revenue, USD Mn) 8.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 8.3.3. Market Opportunity Analysis 8.4. Latin America 8.4.1. Market Analysis, 2013 - 2017 and Forecast, 2018 - 2024 (Revenue, USD Mn) 8.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 8.4.3. Market Opportunity Analysis 8.5. Middle East and Africa 8.5.1. Market Analysis, 2013 - 2017 and Forecast, 2018 - 2024 (Revenue, USD Mn) 8.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 8.5.3. Market Opportunity Analysis 8.6. Global 3D Cell Culture Market - Opportunity Analysis Index, By Technology, By Application, By End User, and Region, 2018 – 2024 9. North America 3D Cell Culture MarketAnalysis,2013 - 2017 and Forecast, 2018 - 2024 (Revenue, USD Mn) 9.1. Technology Analysis 2013 - 2017 and Forecast 2018 - 2024 by Revenue (USD Mn),Y-o-Y Growth (%), and Market Share (%) 9.1.1. Scaffold-free Platforms 9.1.2. Bioreactors 9.1.3. Microchips 9.1.4. Gels 9.1.5. Others 9.2. Application Analysis 2013 - 2017 and Forecast 2018 - 2024 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) 9.2.1. Stem Cell Biology 9.2.2. Drug Discovery 9.2.3. Research 9.2.4. Tissue Engineering 9.2.5. Others 9.3. End User Analysis 2013 - 2017 and Forecast 2018 - 2024 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) 9.3.1. Biotechnology and Pharmaceutical Industries 9.3.2. Hospitals 9.3.3. Others 9.4. Country Analysis 2016 and Forecast 2018 - 2024 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%) 9.4.1. U.S. 9.4.2. Canada 9.5. North America 3D Cell Culture Market - Opportunity Analysis Index, By Technology, By Application, By End User, and Region, 2018 – 2024 9.6. North America 3D Cell Culture Market Dynamics – Trends 10. Europe 3D Cell Culture Market Analysis, 2013 - 2017 and Forecast, 2018 - 2024 (Revenue, USD Mn) 10.1. Technology Analysis 2013 - 2017 and Forecast 2018 - 2024 by Revenue (USD Mn),Y-o-Y Growth (%), and Market Share (%) 10.1.1. Scaffold-free Platforms 10.1.2. Bioreactors 10.1.3. Microchips 10.1.4. Gels 10.1.5. Others 10.2. Application Analysis 2013 - 2017 and Forecast 2018 - 2024 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) 10.2.1. Stem Cell Biology 10.2.2. Drug Discovery 10.2.3. Research 10.2.4. Tissue Engineering 10.2.5. Others 10.3. End User Analysis 2013 - 2017 and Forecast 2018 - 2024 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) 10.3.1. Biotechnology and Pharmaceutical Industries 10.3.2. Hospitals 10.3.3. Others 10.4. Country Analysis 2013 - 2017 and Forecast 2018 - 2024 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%) 10.4.1. Germany 10.4.2. UK 10.4.3. France 10.4.4. Spain 10.4.5. Italy 10.4.6. Russia 10.4.7. Poland 10.4.8. Rest of Europe 10.5. Europe 3D Cell Culture Market - Opportunity Analysis Index, By Technology, By Application, By End User, and Region, 2018 – 2024 10.6. Europe 3D Cell Culture Market Dynamics – Trends 11. Asia-Pacific 3D Cell Culture Market Analysis, 2013 - 2017 and Forecast, 2018 - 2024 (Revenue, USD Mn) 11.1. Technology Analysis 2013 - 2017 and Forecast 2018 - 2024 by Revenue (USD Mn),Y-o-Y Growth (%), and Market Share (%) 11.1.1. Scaffold-free Platforms 11.1.2. Bioreactors 11.1.3. Microchips 11.1.4. Gels 11.1.5. Others 11.2. Application Analysis 2013 - 2017 and Forecast 2018 - 2024 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) 11.2.1. Stem Cell Biology 11.2.2. Drug Discovery 11.2.3. Research 11.2.4. Tissue Engineering 11.2.5. Others 11.3. End User Analysis 2013 - 2017 and Forecast 2018 - 2024 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) 11.3.1. Biotechnology and Pharmaceutical Industries 11.3.2. Hospitals 11.3.3. Others 11.4. Country Analysis2013 - 2017 and Forecast 2018 - 2024 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%) 11.4.1. Japan 11.4.2. China 11.4.3. India 11.4.4. ASEAN 11.4.5. Australia & New Zealand 11.4.6. Rest of Asia-Pacific 11.5. Asia-Pacific 3D Cell Culture Market - Opportunity Analysis Index, By Technology, By Application, By End User, and Region, 2018 – 2024 11.6. Asia-Pacific3D Cell Culture Market Dynamics – Trends 12. Latin America 3D Cell Culture Market Analysis, 2012 - 2012 - 2013 - 2017 and Forecast, 2018 - 2024 (Revenue, USD Mn) 12.1. Technology Analysis 2013 - 2017 and Forecast 2018 - 2024 by Revenue (USD Mn),Y-o-Y Growth (%), and Market Share (%) 12.1.1. Scaffold-free Platforms 12.1.2. Bioreactors 12.1.3. Microchips 12.1.4. Gels 12.1.5. Others 12.2. Application Analysis 2013 - 2017 and Forecast 2018 - 2024 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) 12.2.1. Stem Cell Biology 12.2.2. Drug Discovery 12.2.3. Research 12.2.4. Tissue Engineering 12.2.5. Others 12.3. End User Analysis 2013 - 2017 and Forecast 2018 - 2024 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) 12.3.1. Biotechnology and Pharmaceutical Industries 12.3.2. Hospitals 12.3.3. Others 12.4. Country Analysis 2013 - 2017 and Forecast 2018 - 2024 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%) 12.4.1. Brazil 12.4.2. Mexico 12.4.3. Argentina 12.4.4. Venezuela 12.4.5. Rest of Latin America 12.5. Latin America 3D Cell Culture Market - Opportunity Analysis Index, By Technology, By Application, By End User, and Region, 2018 – 2024 12.6. Latin America 3D Cell Culture Market Dynamics – Trends 13. Middle East and Africa 3D Cell Culture Market Analysis, 2013 - 2017 and Forecast, 2018 - 2024 (Revenue, USD Mn) 13.1. Technology Analysis 2013 - 2017 and Forecast 2018 - 2024 by Revenue (USD Mn),Y-o-Y Growth (%), and Market Share (%) 13.1.1. Scaffold-free Platforms 13.1.2. Bioreactors 13.1.3. Microchips 13.1.4. Gels 13.1.5. Others 13.2. Application Analysis 2013 - 2017 and Forecast 2018 - 2024 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) 13.2.1. Stem Cell Biology 13.2.2. Drug Discovery 13.2.3. Research 13.2.4. Tissue Engineering 13.2.5. Others 13.3. End User Analysis 2013 - 2017 and Forecast 2018 - 2024 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) 13.3.1. Biotechnology and Pharmaceutical Industries 13.3.2. Hospitals 13.3.3. Others 13.4. Country Analysis 2013 - 2017 and Forecast 2018 - 2024 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%) 13.4.1. Gulf Cooperation Council (GCC) Countries 13.4.2. Israel 13.4.3. South Africa 13.4.4. Rest of MEA 13.5. MEA 3D Cell Culture Market - Opportunity Analysis Index, By Technology, By Application, By End User, and Region, 2018 – 2024 13.6. MEA 3D Cell Culture Market Dynamics – Trends 14. Competition Landscape 14.1. Strategic Dashboard of Top Market Players 14.2. Company Profiles (Introduction, Financial Analysis, Drug Class& Service Offerings, Key Developments, Strategies, and SWOT Analysis) 14.2.1. 3D Biomatrix (U.S) 14.2.2. Reinnervate Ltd (U.K) 14.2.3. Becton Dickinson and Company (U.S) 14.2.4. 3D Biotek LLC (U.S) 14.2.5. Thermo Fisher Scientific (U.S) 14.2.6. Global Cell Solutions Inc (U.S) 14.2.7. Synthecon (US) 14.2.8. Kuraray (Japan) 14.2.9. Hamilton Company (US) 14.2.10. Mimetas (Netherlands) 14.2.11. Emulate (US) 14.2.12. Nano3D Biosciences (US) 14.2.13. QGel (Switzerland) 15. Research Methodology 16. Key Assumptions and Acronyms
  • 3D Biomatrix (U.S)
  • Reinnervate Ltd (U.K)
  • Becton Dickinson and Company (U.S)
  • 3D Biotek LLC (U.S)
  • Thermo Fisher Scientific (U.S)
  • Global Cell Solutions Inc (U.S)
  • Synthecon (US)
  • Kuraray (Japan)
  • Hamilton Company (US)
  • Mimetas (Netherlands)
  • Emulate (US)
  • Nano3D Biosciences (US)
  • QGel (Switzerland)